Neurobiological mediators of neuronal apoptosis in experimental neuroAIDS
- PMID: 12628755
- DOI: 10.1016/s0378-4274(02)00434-4
Neurobiological mediators of neuronal apoptosis in experimental neuroAIDS
Abstract
Neuronal loss has often been described at post-mortem in the brain neocortex of patients suffering from AIDS. Neuroinvasive strains of HIV infect macrophages, microglial cells and multinucleated giant cells but not neurones. Processing of the virus by cells of the myelomonocytic lineage yields viral products that, in conjunction with potentially neurotoxic molecules generated by the host, might initiate a complex network of events which leads neurones to death. In particular, the HIV-1 coat glycoprotein gp120 has been proposed as a likely aetiologic agent of the described neuronal loss because it causes death of neurones in culture. More recently, it has been shown that brain neocortical cell death is caused in rat by intracerebroventricular injection of a recombinant gp120 coat protein and this occurs via apoptosis. The latter observation broadens our knowledge in the pathophysiology of the reported neuronal cell loss and opens a new lane of experimental research for the development of novel therapeutic strategies to limit damage to the brain of patients suffering from HIV associated dementia.
Similar articles
-
Exploitation of the HIV-1 coat glycoprotein, gp120, in neurodegenerative studies in vivo.J Neurochem. 2001 Oct;79(1):1-8. doi: 10.1046/j.1471-4159.2001.00537.x. J Neurochem. 2001. PMID: 11595751 Review.
-
The HIV envelope protein gp120 in the nervous system: interactions with nitric oxide, interleukin-1beta and nerve growth factor signalling, with pathological implications in vivo and in vitro.Biochem Pharmacol. 1998 Jul 15;56(2):153-6. doi: 10.1016/s0006-2952(98)00044-6. Biochem Pharmacol. 1998. PMID: 9698067 Review.
-
Evidence that the HIV-1 coat protein gp120 causes neuronal apoptosis in the neocortex of rat via a mechanism involving CXCR4 chemokine receptor.Neurosci Lett. 2001 Oct 19;312(2):67-70. doi: 10.1016/s0304-3940(01)02191-7. Neurosci Lett. 2001. PMID: 11595336
-
[HIV-1 neuropathogenesis: therapeutic strategies against neuronal loss induced by gp120/Tat glycoprotein in the central nervous system].Rev Neurol. 2011 Jan 16;52(2):101-11. Rev Neurol. 2011. PMID: 21271550 Review. Spanish.
-
Human immunodeficiency virus type 1 and its coat protein gp120 induce apoptosis and activate JNK and ERK mitogen-activated protein kinases in human neurons.Ann Neurol. 1997 Dec;42(6):847-56. doi: 10.1002/ana.410420605. Ann Neurol. 1997. PMID: 9403476
Cited by
-
Characterization of cell death pathways in human immunodeficiency virus-associated encephalitis.Am J Pathol. 2005 Sep;167(3):695-704. doi: 10.1016/S0002-9440(10)62044-5. Am J Pathol. 2005. PMID: 16127150 Free PMC article.
-
Arachidonic Acid Cascade and Eicosanoid Production Are Elevated While LTC4 Synthase Modulates the Lipidomics Profile in the Brain of the HIVgp120-Transgenic Mouse Model of NeuroHIV.Cells. 2022 Jul 5;11(13):2123. doi: 10.3390/cells11132123. Cells. 2022. PMID: 35805207 Free PMC article.
-
Interactions between prostaglandins, leukotrienes and HIV-1: possible implications for the central nervous system.Retrovirology. 2012 Jan 11;9:4. doi: 10.1186/1742-4690-9-4. Retrovirology. 2012. PMID: 22236409 Free PMC article. Review.
-
Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS.Neurosci Biobehav Rev. 2008 Jul;32(5):883-909. doi: 10.1016/j.neubiorev.2008.01.004. Epub 2008 Mar 18. Neurosci Biobehav Rev. 2008. PMID: 18430470 Free PMC article. Review.
-
Altered Associations between Pain Symptoms and Brain Morphometry in the Pain Matrix of HIV-Seropositive Individuals.J Neuroimmune Pharmacol. 2018 Mar;13(1):77-89. doi: 10.1007/s11481-017-9762-5. Epub 2017 Sep 2. J Neuroimmune Pharmacol. 2018. PMID: 28866752 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
